Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19-Reference-Cited by-同舟云学术

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

Published:2021-09-27 Issue:1 Volume:291 Page:72-80
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Havervall Sebastian¹^ORCID,Ng Henry¹²^ORCID,Jernbom Falk August³^ORCID,Greilert‐Norin Nina¹^ORCID,Månberg Anna³^ORCID,Marking Ulrika¹,Laurén Ida⁴,Gabrielsson Lena¹,Salomonsson Ann‐Christin¹,Aguilera Katherina¹,Kihlgren Martha¹,Månsson Maja¹,Rosell Axel¹^ORCID,Hellström Cecilia³^ORCID,Andersson Eni³,Olofsson Jennie³^ORCID,Skoglund Lovisa³,Yousef Jamil³^ORCID,Pin Elisa³^ORCID,Lord Martin⁴^ORCID,Åberg Mikael⁵^ORCID,Hedhammar My³,Tegel Hanna³,Dönnes Pierre⁶^ORCID,Phillipson Mia²^ORCID,Nilsson Peter³^ORCID,Klingström Jonas⁷^ORCID,Mangsbo Sara⁴^ORCID,Hober Sophia³^ORCID,Thålin Charlotte¹^ORCID

Affiliation:

1. Department of Clinical Sciences Karolinska Institutet Danderyd Hospital Stockholm Sweden

2. Department of Medical Cell Biology Uppsala University Uppsala Sweden

3. Department of Protein Science, SciLifeLab KTH Royal Institute of Technology Stockholm Sweden

4. Department of Pharmacy Uppsala University Uppsala Sweden

5. Department of Medical Sciences Clinical Chemistry and Science for Life Laboratory Uppsala University Uppsala Sweden

6. SciCross AB Skövde Sweden

7. Centre for Infectious Medicine Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

Funder

Vetenskapsrådet

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13387

Reference23 articles.

1. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study

2. Humoral Immune Response to SARS-CoV-2 in Iceland

3. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

4. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

5. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent symptomatic Omicron infection reduced COVID-19 pneumonia risk during reinfection: A computed tomography–based cohort study;International Journal of Infectious Diseases;2024-09

2. COVID-19: from immune response to clinical intervention;Precision Clinical Medicine;2024-07-18

3. Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis;Frontiers in Public Health;2024-06-20

4. Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women;BMC Infectious Diseases;2024-05-21

5. Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes;Viruses;2024-04-26